Starting cholesterol-lowering statin medications soon after a Type 2 diabetes diagnosis does more than protect your heart—it could also help shield your brain.
According to a nationwide Danish study of over 132,000 adults presented at the European Society of Cardiology (ESC) Congress 2026 and published in The Lancet Regional Health - Europe, early statin use was linked to a reduced risk of long-term dementia.
Key Takeaways
- Early Start Matters: Participants who began statins within 1 year of their Type 2 diabetes diagnosis had a 15% lower relative risk of developing dementia over 10 years compared to non-users.
- Delayed Benefit: Those who waited 1 to 5 years to start statins still saw a benefit, but it was slightly smaller (10% lower relative risk).
- Broad Impact: The protective pattern held true for both men and women.
Why Timing Counts
Managing high "bad" cholesterol (LDL-C) starting in midlife is a key modifiable factor for preventing cognitive decline. Because people with Type 2 diabetes face a higher baseline risk for both high cholesterol and dementia, timely treatment is essential.
While this observational study proves a strong link rather than direct cause-and-effect, researchers highlight that statins are safe, affordable, and already recommended for heart health—making early treatment a simple step with dual benefits. If you have Type 2 diabetes, talk to your doctor about managing your cholesterol early.
